Clinical trial
Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma
NCT00416208 · Janssen-Cilag G.m.b.H, Industry · Completed
Key facts
| NCT number | NCT00416208 |
|---|---|
| Title | Consolidation Therapy With Bortezomib in Elderly Patients With Multiple Myeloma |
| Official title | Consolidation Therapy With Bortezomib in Patients With Multiple Myeloma Aged 61 to 75 |
| Lead sponsor | Janssen-Cilag G.m.b.H, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Bortezomib |
| Enrollment | 154 |
| Start date | Oct 1, 2006 |
| Primary completion | May 1, 2013 |
| Completion | May 1, 2013 |
| First posted | Dec 27, 2006 |
| Last update posted | Mar 5, 2015 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: